Header Logo

Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcomes in patients with pancreatic adenocarcinoma.

Kim RC, Allen KA, Roch AM, McGuire SP, Ceppa EP, Zyromski NJ, Nakeeb A, House MG, Schmidt CM, Nguyen TK. Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcomes in patients with pancreatic adenocarcinoma. Surgery. 2023 03; 173(3):574-580.

View in: PubMed